DF
IDXX icon

Dunhill Financial’s Idexx Laboratories IDXX Stock Holding History

Dunhill Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.64K Sell
6
-2
-25% -$1.28K ﹤0.01% 682
2025
Q4 		$5.11K Buy
8
+1
+14% +$681 ﹤0.01% 595
2025
Q3 		$4.34K Buy
7
+1
+17% +$607 ﹤0.01% 579
2025
Q2 		$3.63K Sell
6
-4
-40% -$1.91K ﹤0.01% 588
2025
Q1 		$4.1K Sell
10
-1
-9% -$434 ﹤0.01% 605
2024
Q4 		$4.72K Sell
11
-6
-35% -$2.63K ﹤0.01% 557
2024
Q3 		$8.74K Buy
17
+9
+113% +$4.37K ﹤0.01% 415
2024
Q2 		$4.11K Buy
8
+1
+14% +$502 ﹤0.01% 425
2024
Q1 		$3.68K Buy
7
+1
+17% +$546 ﹤0.01% 376
2023
Q4 		$3.19K Buy
+6
New +$2.82K ﹤0.01% 359

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dunhill Financial's IDXX Position: Q1 2026 in Review

Dunhill Financial reduced its Idexx Laboratories (IDXX) stake by 25% in Q1 2026, selling an estimated $1.28K and leaving 6 shares worth $3.64K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

Dunhill Financial first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.74K in Q3 2024. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Dunhill Financial held 6 shares of Idexx Laboratories worth $3.64K as of Q1 2026.
  • Dunhill Financial sold 2 Idexx Laboratories shares in Q1 2026, an estimated $1.28K.
  • Idexx Laboratories made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #682 holding.
  • Dunhill Financial first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
  • Dunhill Financial's Idexx Laboratories position peaked at $8.74K in Q3 2024.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.